[Directions of investigations for new drugs in asthma].
Bronchial asthma is affecting more than 300 million people worldwide and in every 15-20 years additional 100 million patients are expected. About 5-10% of asthmatic patients have severe disease and fails to respond to conventional therapy. For this reason a new therapy or improvement in available treatment are under investigations. More knowledge of asthma mechanisms has led to monoclonal antibody, inhaled anti-oxidants and new combination therapy with corticosteroids. Similarly, biological agents directed against IL-13 and immunomodulators influenced T-regulatory cells are likely to be successful in the future therapy.